Adaptive Autism Intervention for Toddlers with Autism
(CAIT Trial)
Trial Summary
What is the purpose of this trial?
This trial tests a program to help toddlers with autism improve their social and communication skills. The program starts with play-based activities and is adjusted based on each child's progress. These activities have been shown to improve social communication in young children with autism. The goal is to find the best way to support these children in everyday settings.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It focuses on behavioral interventions for toddlers with autism.
Do I have to stop my child's current medications for this trial?
The trial protocol does not specify whether participants must stop taking their current medications, so it's best to discuss this with the trial coordinators or your child's doctor.
What data supports the idea that Adaptive Autism Intervention for Toddlers with Autism is an effective treatment?
The available research shows that Adaptive Autism Intervention for Toddlers with Autism, such as JASPER, is effective in improving language and play skills in young children with autism. One study found that children who received joint attention and play interventions showed greater improvements in language skills compared to those who did not receive these interventions. Another study demonstrated that teachers could successfully implement these interventions in classrooms, leading to significant improvements in joint attention and play skills. Additionally, a pilot study showed that minimally verbal children with autism who received JASPER treatment had more diverse play and better engagement in the classroom. These findings suggest that this treatment can effectively enhance important developmental skills in children with autism.12345
What data supports the effectiveness of the treatment jasPEER, JASPER with a peer, JASPER, Joint Attention Symbolic Play Engagement & Regulation, JASPER Plus+, JASPER Plus+, JASPER with Structured Teaching, Structured Teaching, Structured Teaching, Direct Instruction, Applied Behavior Analysis (ABA) component for toddlers with autism?
Research shows that interventions focusing on joint attention and symbolic play, like JASPER, can significantly improve language outcomes and play diversity in young children with autism. These treatments help enhance social engagement and communication skills, which are crucial for children with autism.12345
What safety data exists for the Adaptive Autism Intervention for Toddlers with Autism?
The studies provided do not directly address safety data for the intervention. However, they suggest that interventions like JASPER, which focus on joint attention and play, are beneficial and can be implemented in various settings (classroom, parent-mediated) without reported adverse effects. These interventions have shown improvements in joint attention, play skills, and language outcomes in young children with autism, indicating they are generally well-tolerated and effective.13456
Is the Adaptive Autism Intervention for Toddlers with Autism safe for humans?
Is JASPER a promising treatment for toddlers with autism?
Yes, JASPER is a promising treatment for toddlers with autism. It helps improve important skills like joint attention and play, which are crucial for social interaction and communication. Studies show that children who receive JASPER make significant progress in these areas, and even brief sessions can lead to noticeable improvements.14567
How is the JASPER treatment different from other autism treatments?
JASPER is unique because it focuses on improving joint attention and symbolic play skills in young children with autism, using a developmentally grounded approach that involves parents and teachers in everyday routines. This treatment is distinct from others as it emphasizes building social-communicative skills through play and interaction, rather than traditional behavioral therapies.14567
Eligibility Criteria
This trial is for toddlers aged 2-3 with autism spectrum disorder (ASD) who are receiving early intervention in East Harlem and the Bronx, NY. They must have a clinical ASD diagnosis or ADOS-2 confirmation, and their caregivers must consent to learn intervention strategies if required. Children with co-morbid disorders like cerebral palsy or Down syndrome cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Stage 1 Treatment
Participants receive JASPER intervention for either 6 or 12 weeks, depending on randomization
Stage 2 Treatment
Participants continue with JASPER or are augmented with JASPER Plus+ based on response
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- jasPEER
- JASPER
- JASPER Plus+
- Structured Teaching
JASPER is already approved in United States for the following indications:
- Autism Spectrum Disorder (ASD), specifically for improving social communication and play skills in minimally verbal children
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor
National Institutes of Health (NIH)
Collaborator